The Regulators Associated With N6-Methyladenosine in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma Reveal New Clinical and Prognostic Markers
Shuzhen Tan(Guangdong Medical College), Xiao Zhu(Guangdong Medical College), Guosheng Liang(First Affiliated Hospital of Guangzhou Medical University), Zhilin Zou(Guangdong Medical College), Kai Li(Hospital Authority), Yingqi Li(Northeastern University), Wenqing Chen(Wuhan University), Minhua Li(Baylor College of Medicine), Jianhao Kang(Guangdong Medical College), Guoliang Pi(Hubei Cancer Hospital), Zhenye Tang(Guangdong Medical College), Zesong Li(North China Electric Power University)
Cited by 11
Related Papers
Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma
|Nature|2019|982
mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges
|Cell & Bioscience|2020|935
Overexpression of Insig-1 in the livers of transgenic mice inhibits SREBP processing and reduces insulin-stimulated lipogenesis
|Journal of Clinical Investigation|2004|265